ORIC — ORIC Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Oric Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview
Brief: Oric Pharmaceuticals To Present Preclinical Data On Cd73 Inhibitor Program In Multiple Myeloma At The 64Th American Society Of Hematology (Ash) Annual Meeting
Oric Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Oric Pharmaceuticals Reports Second Quarter 2022 Financial Results And Operational Update
Oric Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Oric Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chinese ADRs, Star Equity, Starbucks
U.S. STOCKS ON THE MOVE-Social media apps, Curis, Gores Guggenheim
U.S. STOCKS ON THE MOVE-Twitter, SPI Energy, Red Cat
Oric Pharma rises as Citi ups to 'buy' on cancer drug promise
H.C. Wainwright lowers rating, removes PT on Oric Pharmaceuticals
Oric Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Oric Pharmaceuticals Reports Fourth Quarter Loss Per Share Of $0.58
Oric Pharmaceuticals Inc expected to post a loss of 57cents a share - Earnings Preview
Oric Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: ORIC Pharmaceuticals Announces Regulatory Clearance Of Clinical Trial Application
Brief: Oric Pharmaceuticals Appoints Angie You To Its Board
Oric Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Oric Pharmaceuticals Reports Third Quarter 2021 Financial Results